Investigators
Muhayimpundu Ribakare, Sabin Nsanzimana, Eric Remera, Augustin Mulindabigwi, Gentille Musengimana, Dieudonne sebuhoro, Dominique savio Byiringiro Habimana, Florence kayitesi, Innocent Kamali, Emmanuel Yoboka, David Kamanda, Max Kabalisa, Willian Uwizeye, Jules Mugabo, Emil Yvan Mwikarago, Alise Kabanda, Canisious Musoni, Jared Omolo, Godfre Gato, Richard Mwesigwa, Prosper Karame, Christina Mwangi, Ida kankindi, Clarisse Musanabaganwa, Eugenie Kayirangwa, Tally Leigh, S. samuel Malamba, Gene Macdonald.
Study information
- Research Area: HIV
- Research type: longitudinal cross-sectional survey
- Start date: Jul 01, 2018
- End date: Jul 31, 2019
Study aim of the objectives
To evaluate the current status on ARVs drug resistance.
Study setting/Area (Location)
Rwanda- Countrywide
Implementing institution
Rwanda Biomedical Center
Department/Division
HIV
Impact on Policy
